Outcome Determinants of Fusariosis in a Tertiary Care Cancer Center: The Impact of Neutrophil Recovery
- 1 January 2004
- journal article
- research article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 45 (1) , 139-141
- https://doi.org/10.1080/1042819031000149386
Abstract
Factors associated with failure of antifungal therapy were examined in 42 cancer patients with fusariosis (1987 – 1997). Thirty-six patients (86%) had leukemia and 39 (93%) were neutropenic. Disseminated infection was the most common presentation. The majority (83%) received amphotericin B-based therapy. Thirty patients (71%) failed therapy. No patient with persistent neutropenia responded.Keywords
This publication has 5 references indexed in Scilit:
- Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in childrenThe Pediatric Infectious Disease Journal, 2002
- Efficacy and Safety of Voriconazole in the Treatment of Acute Invasive AspergillosisClinical Infectious Diseases, 2002
- Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International ConsensusClinical Infectious Diseases, 2002
- Fusarium, a Significant Emerging Pathogen in Patients With Hematologic Malignancy: Ten Years' Experience at a Cancer Center and Implications for ManagementBlood, 1997
- Effectiveness of an Oral Triazole for Opportunistic Mold Infections in Patients with Cancer: Experience with SCH 39304Clinical Infectious Diseases, 1993